We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.56B
AUM Growth
+$200M
Cap. Flow
-$12.2M
Cap. Flow %
-0.48%
Top 10 Hldgs %
35.03%
Holding
185
New
38
Increased
44
Reduced
32
Closed
58

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$34.8M
2
AGN.PRA
Allergan plc
AGN.PRA
+$31.9M
3
EBAY icon
eBay
EBAY
+$28.5M
4
YUM icon
Yum! Brands
YUM
+$27.1M
5
HES
Hess
HES
+$22.8M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Consumer Discretionary 10.07%
3 Technology 9.69%
4 Consumer Staples 5.72%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCM
176
PUT
DELISTED
BROADCOM CORP CL-A
BRCM
-215,000
Closed -$9.31M
ACT.PRA
177
DELISTED
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
-20,000
Closed -$20.2M
MDVN
178
DELISTED
MEDIVATION, INC.
MDVN
-200,000
Closed -$12.9M
TWC
179
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-31,900
Closed -$4.78M
RPRX
180
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
-200,000
Closed -$1.72M

Similar funds

Kingdon Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Kingdon Capital Management held 185 positions worth $2.56B, up 8.5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kingdon Capital Management's Q2 2015 filing shows 38 new, 44 increased, 32 reduced and 58 closed positions. Its largest new stake was Allergan plc: 30,500 shares worth $31.9M. The largest sale was ANACOR PHARMACEUTICALS INC COM, an estimated $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Kingdon Capital Management's largest Q2 2015 buy was Allergan plc: 30,500 shares worth $31.9M.
  • Kingdon Capital Management added most to Adobe in Q2 2015, an estimated $34.8M increase.
  • Kingdon Capital Management's biggest Q2 2015 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $29.6M.
  • Kingdon Capital Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $23M.
  • Kingdon Capital Management's ten largest holdings make up 35% of its $2.56B portfolio in Q2 2015.
  • Kingdon Capital Management opened 38 new positions and closed 58 in Q2 2015.
  • Kingdon Capital Management's portfolio value rose 8.5% quarter-over-quarter to $2.56B.

Based on Kingdon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.